VXCO-100

· Vaccine Company, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VXCO-100, covering 2024-12-10 to 2024-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa [Phase 1]